Danone beats Q2 forecasts on China dairy, nutrition sales
Strong demand offsets weak US creamer performance
31 July 2025
1 minute read
By: Danone on Wednesday reported second-quarter sales that beat expectations, boosted by strong demand in China for infant milk formula and medical nutrition products, offsetting weakness in coffee creamers amid a competitive US market, reported Reuters.
The French consumer goods group, whose brands include Evian and Badoit water and Activia yoghurt, said second-quarter sales rose 4.1% on a like-for-like basis, compared with expectations of 3.8% in a company-provided analysts' consensus.
Danone's recurring operating income for the first half of 2025 was 1.811 billion euros ($2.09 billion), with a margin of 13.2% of sales against 12.7% a year ago.
The company reiterated its full-year 2025 forecast was in line with its mid-term ambition of like-for-like sales growth of between 3% and 5%, with recurring operating income growing faster than sales.
($1 = 0.8654 euros)
